| Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons I Katona, B Sperlágh, A Sı́k, A Köfalvi, ES Vizi, K Mackie, TF Freund The Journal of neuroscience 19 (11), 4544-4558, 1999 | 1486 | 1999 |
| Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus B Sperlágh, A Köfalvi, J Deuchars, L Atkinson, C J. Milligan, NJ Buckley, ... Journal of neurochemistry 81 (6), 1196-1211, 2002 | 327 | 2002 |
| GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus I Katona, B Sperlagh, Z Maglóczky, E Santha, A Köfalvi, S Czirjak, ... Neuroscience 100 (4), 797-804, 2000 | 316 | 2000 |
| Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis A Köfalvi, RJ Rodrigues, C Ledent, K Mackie, ES Vizi, RA Cunha, ... Journal of Neuroscience 25 (11), 2874-2884, 2005 | 273 | 2005 |
| Molecular reorganization of endocannabinoid signalling in Alzheimer’s disease J Mulder, M Zilberter, SJ Pasquare, A Alpar, G Schulte, SG Ferreira, ... Brain 134 (4), 1041-1060, 2011 | 229 | 2011 |
| Modification upon aging of the density of presynaptic modulation systems in the hippocampus PM Canas, JMN Duarte, RJ Rodrigues, A Köfalvi, RA Cunha Neurobiology of aging 30 (11), 1877-1884, 2009 | 165 | 2009 |
| Differential glutamate‐dependent and glutamate‐independent adenosine A1 receptor‐mediated modulation of dopamine release in different striatal compartments J Borycz, MF Pereira, A Melani, RJ Rodrigues, A Köfalvi, L Panlilio, ... Journal of neurochemistry 101 (2), 355-363, 2007 | 141 | 2007 |
| Behavioral phenotyping of parkin-deficient mice: looking for early preclinical features of Parkinson's disease. PRD Rial D, Castro AA, Machado N, Garção P, Gonçalves FQ, Silva HB, Tomé AR ... PlosOne 9 (12), e114216, 2014 | 136* | 2014 |
| Caffeine regulates frontocorticostriatal dopamine transporter density and improves attention and cognitive deficits in an animal model of attention deficit hyperactivity disorder P Pandolfo, NJ Machado, A Köfalvi, RN Takahashi, RA Cunha European Neuropsychopharmacology 23 (4), 317-328, 2013 | 132 | 2013 |
| Cannabis: a treasure trove or pandora's box? K Solymosi, A Köfalvi Mini reviews in medicinal chemistry 17 (13), 1223-1291, 2017 | 112 | 2017 |
| CB1 receptor antagonism increases hippocampal acetylcholine release: site and mechanism of action A Degroot, A Köfalvi, MR Wade, RJ Davis, RJ Rodrigues, N Rebola, ... Molecular pharmacology 70 (4), 1236-1245, 2006 | 104 | 2006 |
| Cannabinoids inhibit the synaptic uptake of adenosine and dopamine in the rat and mouse striatum P Pandolfo, V Silveirinha, A Santos-Rodrigues, L Venance, C Ledent, ... European journal of pharmacology, 2011 | 101 | 2011 |
| Supersensitivity of P2X7 receptors in cerebrocortical cell cultures after in vitro ischemia K Wirkner, A Köfalvi, W Fischer, A Günther, H Franke, H Gröger‐Arndt, ... Journal of neurochemistry 95 (5), 1421-1437, 2005 | 100 | 2005 |
| Cannabinoids inhibit the release of [3H]glutamate from rodent hippocampal synaptosomes via a novel CB1 receptor‐independent action A Köfalvi, ES Vizi, C Ledent, B Sperlágh European journal of neuroscience 18 (7), 1973-1978, 2003 | 88 | 2003 |
| Glutamate-induced and NMDA receptor-mediated neurodegeneration entails P2Y1 receptor activation AP Simões, CG Silva, JM Marques, D Pochmann, LO Porciúncula, ... Cell Death & Disease 9 (3), 297, 2018 | 83 | 2018 |
| Pre‐synaptic adenosine A2A receptors control cannabinoid CB1 receptor‐mediated inhibition of striatal glutamatergic neurotransmission A Martire, MT Tebano, V Chiodi, SG Ferreira, RA Cunha, A Köfalvi, ... Journal of neurochemistry 116 (2), 273-280, 2011 | 77 | 2011 |
| Control of glutamate release by complexes of adenosine and cannabinoid receptors A Köfalvi, E Moreno, A Cordomí, NS Cai, V Fernández-Dueñas, ... BMC biology 18, 1-21, 2020 | 72 | 2020 |
| Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer's disease A Köfalvi, C Lemos, AM Martín-Moreno, BS Pinheiro, L García-García, ... Neuropharmacology 110, 519-529, 2016 | 62 | 2016 |
| Neuronal adenosine A2A receptors are critical mediators of neurodegeneration triggered by convulsions PM Canas, LO Porciúncula, AP Simões, E Augusto, HB Silva, ... Eneuro 5 (6), 2018 | 61 | 2018 |
| Adenosine A2b receptors control A1 receptor‐mediated inhibition of synaptic transmission in the mouse hippocampus FQ Gonçalves, J Pires, A Pliassova, R Beleza, C Lemos, JM Marques, ... European Journal of Neuroscience 41 (7), 878-888, 2015 | 59 | 2015 |
Rodrigo CunhaUniversity of CoimbraVerified email at fmed.uc.pt
